[
  {
    "ts": null,
    "headline": "Pfizer (NYSE:PFE) Exceeds Sales Milestone With Cresemba In Asia Pacific And China",
    "summary": "Pfizer (NYSE:PFE) announced robust sales for the antifungal drug Cresemba in partnership with Basilea Pharmaceutica Ltd, marking significant growth in key Asian markets. Despite this achievement, Pfizer's stock price was relatively flat last week, reflecting a broader market trend rather than significant movements unique to the company. The company's announcements, including significant clinical trial results and strategic drug market expansions, provided positive context. However, these...",
    "url": "https://finnhub.io/api/news?id=d73409bbf022823b94180be5c8076b85a7d94359a07441fe474e3b9976bca149",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749144331,
      "headline": "Pfizer (NYSE:PFE) Exceeds Sales Milestone With Cresemba In Asia Pacific And China",
      "id": 135063881,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer (NYSE:PFE) announced robust sales for the antifungal drug Cresemba in partnership with Basilea Pharmaceutica Ltd, marking significant growth in key Asian markets. Despite this achievement, Pfizer's stock price was relatively flat last week, reflecting a broader market trend rather than significant movements unique to the company. The company's announcements, including significant clinical trial results and strategic drug market expansions, provided positive context. However, these...",
      "url": "https://finnhub.io/api/news?id=d73409bbf022823b94180be5c8076b85a7d94359a07441fe474e3b9976bca149"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Inc. stock underperforms Thursday when compared to competitors",
    "summary": "Pfizer Inc. stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=61ccbf560a8a1b17dc56ca428d7497ee5ad16e26471baae857aacabaf693eb4b",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749141360,
      "headline": "Pfizer Inc. stock underperforms Thursday when compared to competitors",
      "id": 135075448,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Pfizer Inc. stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=61ccbf560a8a1b17dc56ca428d7497ee5ad16e26471baae857aacabaf693eb4b"
    }
  },
  {
    "ts": null,
    "headline": "5 Bargain Stocks With Low P/S Ratios & High Growth Return Potential",
    "summary": "The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like JAKK, GDOT, SIG, ROCK and PFE hold promise.",
    "url": "https://finnhub.io/api/news?id=eec19de6e5ae6058e87273f19e5197f7bbc32077f76f250aa773e478def7323e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749139800,
      "headline": "5 Bargain Stocks With Low P/S Ratios & High Growth Return Potential",
      "id": 135063882,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like JAKK, GDOT, SIG, ROCK and PFE hold promise.",
      "url": "https://finnhub.io/api/news?id=eec19de6e5ae6058e87273f19e5197f7bbc32077f76f250aa773e478def7323e"
    }
  },
  {
    "ts": null,
    "headline": "Pre-Tariff Pharma Stockpiling Gives Irish Economy a Huge Booster Shot",
    "summary": "Ireland’s economy grew three times as rapidly as first estimated in the first quarter. That was driven by stockpiling of pharmaceuticals and other goods by U.S. businesses ahead of threatened tariffs.",
    "url": "https://finnhub.io/api/news?id=6a764a9c55cd08349eb562c42db48bdd99c0df18c9c9bc39199764d0399cba34",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749129059,
      "headline": "Pre-Tariff Pharma Stockpiling Gives Irish Economy a Huge Booster Shot",
      "id": 135063711,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Ireland’s economy grew three times as rapidly as first estimated in the first quarter. That was driven by stockpiling of pharmaceuticals and other goods by U.S. businesses ahead of threatened tariffs.",
      "url": "https://finnhub.io/api/news?id=6a764a9c55cd08349eb562c42db48bdd99c0df18c9c9bc39199764d0399cba34"
    }
  },
  {
    "ts": null,
    "headline": "Alexandria Real Estate: Examining The Bear Side On This One",
    "summary": "Alexandria Real Estate: Examining The Bear Side On This One",
    "url": "https://finnhub.io/api/news?id=04fb1511cc019becd7337fc8c72aee37a65700e1cadf489900b19a5b25e3c127",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749121562,
      "headline": "Alexandria Real Estate: Examining The Bear Side On This One",
      "id": 135046936,
      "image": "",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=04fb1511cc019becd7337fc8c72aee37a65700e1cadf489900b19a5b25e3c127"
    }
  },
  {
    "ts": null,
    "headline": "Better High-Yield Dividend Stock to Buy Now: Pfizer vs. Prologis",
    "summary": "Super-high-yield stocks often deliver heaps of passive income early on, but they aren't famous for rapid payout raises.  Pfizer offers a sky-high yield, but its payout has been rising slowly.  Prologis offers a decent yield, and it's been raising its payout at an exciting pace.",
    "url": "https://finnhub.io/api/news?id=fef239870cb851b9846fe868aa7f1c787fa4023beea463771555107e8b4fe78a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749108840,
      "headline": "Better High-Yield Dividend Stock to Buy Now: Pfizer vs. Prologis",
      "id": 135043630,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Super-high-yield stocks often deliver heaps of passive income early on, but they aren't famous for rapid payout raises.  Pfizer offers a sky-high yield, but its payout has been rising slowly.  Prologis offers a decent yield, and it's been raising its payout at an exciting pace.",
      "url": "https://finnhub.io/api/news?id=fef239870cb851b9846fe868aa7f1c787fa4023beea463771555107e8b4fe78a"
    }
  },
  {
    "ts": null,
    "headline": "Here Are All 6 Stocks I've Bought Through 5 Months of 2025",
    "summary": "A volatile stock market represents an ideal opportunity for long-term investors to pounce.",
    "url": "https://finnhub.io/api/news?id=aa04c5dc418950f8f58ba4f9ec16130db5eccca6e8b69cf438664140c8b952ea",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749107160,
      "headline": "Here Are All 6 Stocks I've Bought Through 5 Months of 2025",
      "id": 135043631,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "A volatile stock market represents an ideal opportunity for long-term investors to pounce.",
      "url": "https://finnhub.io/api/news?id=aa04c5dc418950f8f58ba4f9ec16130db5eccca6e8b69cf438664140c8b952ea"
    }
  },
  {
    "ts": null,
    "headline": "Basilea Pharmaceutica Ltd, Announces Continued Strong Sales Performance of the Antifungal Cresemba® (isavuconazole) by Its License Partner Pfizer Inc",
    "summary": "Basilea Pharmaceutica Ltd, announced that the continued strong sales performance of the antifungal Cresemba® by its license partner Pfizer Inc. in the Asia Pacific region and China exceeded the...",
    "url": "https://finnhub.io/api/news?id=359e4f606ea5acc5cfd17b66b845ec181b8ba9865b1f9c241b0ac1bd414ce969",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749090021,
      "headline": "Basilea Pharmaceutica Ltd, Announces Continued Strong Sales Performance of the Antifungal Cresemba® (isavuconazole) by Its License Partner Pfizer Inc",
      "id": 135040280,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "Basilea Pharmaceutica Ltd, announced that the continued strong sales performance of the antifungal Cresemba® by its license partner Pfizer Inc. in the Asia Pacific region and China exceeded the...",
      "url": "https://finnhub.io/api/news?id=359e4f606ea5acc5cfd17b66b845ec181b8ba9865b1f9c241b0ac1bd414ce969"
    }
  }
]